Bro's VerdictDeep Dive
Rating
HOLD
Confidence
60%
Target Price
A$26.50
Upside
+5.3%
Horizon
medium
QBE is a capital return story at ~12.4x NTM P/E on revised $2.03 EPS, with a 4.64% yield and a $450m buyback supporting total returns near 8-9% without needing multiple expansion. However, the valuation picture is mixed — EV/EBIT and EV/Revenue screen rich versus their own history, implying the low P/E reflects a depressed earnings base rather than a genuine discount, and the $25.37 consensus target sits essentially at the current price. With balanced risk/reward, the analyst recommends Hold with a $26.50 target (~5% upside plus dividend), upgrading only on a decisive break above the $25.83 52-week high with sustained ROE above 17%.
Executive Summary
Financial Snapshot
Forward Outlook
Valuation Analysis
Key Risks & Catalysts
Risks
Catalysts
Investment Thesis
QBE is a capital return story trading at a modest forward multiple. At ~12.4x NTM P/E on the revised $2.03 EPS, with a 4.64% yield and a $450m buyback, the stock offers a total return profile near 8 to 9% without requiring multiple expansion. The 17.7% 1H26 ROE confirms the business is clearing its 15%+ medium term target, and consensus EPS is being revised up, the single most supportive signal in the data set.
The valuation picture is genuinely mixed. The 12.0x trailing P/E against a 21x two year average looks compelling, but EV/EBIT and EV/Revenue both sit well above their own history, implying the low P/E reflects a depressed earnings base rather than a pure discount. This argues for caution on any re rating thesis and favours earnings delivery as the return driver.
Recommendation: Hold with a 12 month price target of $26.50, roughly 5% upside plus the dividend, applying a modest premium to the $25.37 consensus to reflect buyback support and upward EPS revisions. The risk/reward is balanced: the yield and buyback provide downside support near the $22 P/BV implied level, while the soft premium cycle and catastrophe exposure cap upside. A decisive break above the $25.83 52 week high on sustained ROE above 17% would justify upgrading to Buy.